Isolated P27 protein, nucleic acid molecules encoding same, methods of identifying agents acting on same, and uses of said agents
US6635450B1 · kind B1 · utility
0Cited by
6References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 28, 1997 |
| Grant date | Oct 21, 2003 |
| Priority date | — |
| Expiry date | Feb 13, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An isolated protein designated p27 is disclosed. The p27 protein has an apparent molecular weight of about 27 kD, and is capable of binding to and inhibiting the activation of a cyclin E-Cdk2 complex. A nucleic acid sequence encoding p27 protein is disclosed, as well as a method for producing p27 in cultured cells. in vitro assays for discovering agents which effect the activity of p27 are also provided. Methods of diagnosing and treating hypoproliferative and hyperproliferative disorders are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.